Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000
Management of Intracranial Bleeding Associated with Anticoagulation: Balancing the Risk of Further Bleeding Against Thromboembolism From Prosthetic Heart Valves
JNNP 69:396-398, Crawley,F. et al, 2000
Efficient Operation of a High-Volume Anticoagulation Clinic
Am J Health Syst Pharm 56:443-449, Foss,M.T.,et al, 1999
Secondary Prevention after Cerebral Ischaemia of Presumed Arterial Origin:Is Aspirin Still the Touchstone?
JNNP 66:557-559, Algra,A.,et al, 1999
Preventing Stroke in Patients with Atrial Fibrillation
JAMA 281:1830-1835, Ezekowitz,M.D.&Levine,J.A., 1999
Measurement of the Urinary Lactate:Creatinine Ratio for the Early Identification of Newborn Infants at Risk for Hypoxic-Ischemic Encephalopathy
NEJM 341:328-335,364, Huang,C.,et al, 1999
Major Bleeding During Anticoagulation after Cerebral Ischemia, Patterns and Risk Factors
Neurol 53:1319-1327, Gorter,J.W., 1999
Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation:A Meta-Analysis
Ann Int Med 131:492-501,537, Hart,R.G.,et al, 1999
Clinicopath Conf,Thrombosis of St. Jude Medical Aortic Valve,Intra-Cerebral Lobar Hemorrhage, Case 37-1999
NEJM 341:1829-1835, , 1999
Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
JAMA 279:657-662, 7021998., Hylek,E.M.,et al, 1998
Fixed Minidose Warfarin & Aspirin Alone & in Comb vs Adjusted-Dose Warfarin for Stroke Prevent in Atrial Fib
Arch Int Med 158:1513-1521, 14871998., Gullov,A.L.,et al, 1998
Fiddleheads and the International Normalized Ratio
NEJM 338:1550, Bartle,W.R.&Ferland,G., 1998
Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Neurol 51:674-681, Hart,R.G.,et al, 1998
Comparison of an Anticoagulation Clinic With Usual Medical Care: Anticoagulation Control, Patient Outcomes, and Health Care Costs
Arch Int Med 158:1641-1647, Chiquette,E.,et al, 1998
Evaluation of Neurologic Function in Gulf War Veterans:A Blinded Case-Control Study
JAMA 227:223-230, 2591997., Haley,R.W.,et al, 1997
Botulism Surveillance and Emergency Response
JAMA 278:433-435, Shapiro,R.L.,et al, 1997
Warfarin Use Among Patients with Atrial Fibrillation
Stroke 28:2382-2389, Brass,L.M.,et al, 1997
A Randomized Trial of Anticoagulants Vs Aspirin After Cerebral Ischemia of Presumed Arterial Origin
SPIRIT Study Group, Ann Neurol 42:857-8651997., , 1997
Risk of Stroke During Long-Term Anticoagulant Therapy in Patients After Myocardial Infarction
Ann Neurol 39:301-307, 2811996., Azar,A.J.,et al, 1996
An Analysis of Lowest Effective Intensity of Prophylactic Anticoagulation for Pts with Nonrheumatic Atrial Fib
NEJM 335:540-546, 5871996., Hylek,E.M.,et al, 1996
The"Gulf War Syndrome"-Is There Evidence of Dysfunction in the Nervous System
JNNP 60:449-451, Jamal,G.A.,et al, 1996
Adjusted-Dose Warfarin Vs Low-Intens
Fixed-Dose Warfarin+Aspirin for High-Risk Pts with Atrial Fib, SPAFIII Invest, Lancet 348:633-638996, , 1996
Status of Antithrombotic Therapy for Patients with Atrial Firbrillation in University Hospitals
Arch Int Med 156:2311-2316, Albers,G.W.,et al, 1996
Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves
NEJM 333:11-17, 541995., Cannegieter,S.C.,et al, 1995
US National Survey of Physician Practices for the Secondary & Tertiary Prevention of Ischemic Stroke:Common Practices
Stroke 26:1607-1615, Goldstein,L.B.,et al, 1995
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
NEJM 332:993-997, 10251995., Khamashta,M.A.,et al, 1995
Optimal Oral Anticoag Therapy in Pts with Nonrheumatic Atrial Fib & Recent Cerebral Ischemia
European Atrial Fib Study Group, NEJM 333:5-10, 54995., , 1995
Laboratory Monitoring of Oral Anticoagulant Therapy:Are We Being Misled?
Neurol 43:468-470, Albers,G.W., 1993
Effect of Low-Intensity Warfarin Anticoag on Level of Activity of Hemostatic System in Pts with Atrial Fib
Stroke 24:1360-1365, Kistler,J.P.,et al, 1993
Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy
NEJM 329:696-702, Eckman,M.H.,et al, 1993
Anticoagulant-Related Bleeding:Clinical Epidemiology, Prediction, and Prevention
Am J Med 95:315-328, Landefeld,C.S.&Beyth,R.J., 1993
A Glossary of What is Available
Chemical Weapons, Biological Weapons, USA Today, p. 3A, Feb 8., , 1991